|Bid||166.50 x 100|
|Ask||174.50 x 300|
|Day's Range||172.88 - 173.56|
|52 Week Range||139.07 - 173.64|
|PE Ratio (TTM)||31.63|
|Earnings Date||Jul 26, 2017 - Jul 31, 2017|
|Dividend & Yield||0.60 (0.35%)|
|1y Target Est||185.41|
On January 4, 2017, Abbott Laboratories (ABT) announced the completion of its acquisition of St. Jude Medical.
In 1Q17, Abbott Laboratories (ABT) managed to report adjusted earnings per share (or EPS) of nearly $0.48, ~$0.05 higher than analysts' estimated EPS.
Thermo Fisher's strong reputation with consumers in a 'highly-fragmented' industry will create organic growth opportunities at the 'likely' expense of weaker competition, Cantor said.